ZA9610886B - Bioadhesives solid dosage form. - Google Patents

Bioadhesives solid dosage form.

Info

Publication number
ZA9610886B
ZA9610886B ZA9610886A ZA9610886A ZA9610886B ZA 9610886 B ZA9610886 B ZA 9610886B ZA 9610886 A ZA9610886 A ZA 9610886A ZA 9610886 A ZA9610886 A ZA 9610886A ZA 9610886 B ZA9610886 B ZA 9610886B
Authority
ZA
South Africa
Prior art keywords
solid dosage
bioadhesives
dosage form
dosage forms
compositions
Prior art date
Application number
ZA9610886A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA9610886B publication Critical patent/ZA9610886B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9610886A 1995-12-27 1996-12-23 Bioadhesives solid dosage form. ZA9610886B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95203649 1995-12-27

Publications (1)

Publication Number Publication Date
ZA9610886B true ZA9610886B (en) 1998-06-23

Family

ID=8221021

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610886A ZA9610886B (en) 1995-12-27 1996-12-23 Bioadhesives solid dosage form.

Country Status (27)

Country Link
US (1) US6303147B1 (ru)
EP (1) EP0869772B1 (ru)
JP (1) JP4317264B2 (ru)
KR (1) KR100459029B1 (ru)
CN (1) CN1146401C (ru)
AT (1) ATE206304T1 (ru)
AU (1) AU713849B2 (ru)
BR (1) BR9612291A (ru)
CA (1) CA2232152C (ru)
CY (1) CY2269B1 (ru)
CZ (1) CZ298690B6 (ru)
DE (1) DE69615704T2 (ru)
DK (1) DK0869772T3 (ru)
EA (1) EA000818B1 (ru)
ES (1) ES2164940T3 (ru)
HK (1) HK1015680A1 (ru)
HU (1) HU228350B1 (ru)
IL (1) IL123636A (ru)
NO (1) NO320015B1 (ru)
NZ (1) NZ325844A (ru)
PL (1) PL186278B1 (ru)
PT (1) PT869772E (ru)
SI (1) SI0869772T1 (ru)
SK (1) SK283370B6 (ru)
TR (1) TR199800894T2 (ru)
WO (1) WO1997024109A1 (ru)
ZA (1) ZA9610886B (ru)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
US20080213378A1 (en) * 1998-10-01 2008-09-04 Elan Pharma International, Ltd. Nanoparticulate statin formulations and novel statin combinations
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
CA2371940C (en) 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
US7503493B2 (en) * 1999-10-25 2009-03-17 Silverbrook Research Pty Ltd Method and system for digitizing freehand graphics with user-selected properties
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
US7198795B2 (en) * 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
EP1236466B1 (en) * 2001-02-28 2011-09-21 Axiomedic Ltd. Solid self-adhesive compositions for topical treatment of oral mucosal disorders
US8980334B2 (en) * 2001-02-28 2015-03-17 Axiomedic Ltd. Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US7846478B2 (en) * 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
ATE464880T1 (de) 2002-02-04 2010-05-15 Elan Pharma Int Ltd Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
EP1667681A4 (en) 2003-10-03 2009-09-30 Astron Res Pvt Ltd NEW TRANSMUCOSAL ADMINISTRATION SYSTEM
EA011862B1 (ru) * 2004-03-24 2009-06-30 Актавис Груп Хф. Композиции рамиприла
EP2468266A3 (en) * 2004-04-22 2012-10-24 AcuCort AB Pharmaceutical compositions for acute glucocorticoid therapy
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
SG164375A1 (en) 2004-08-13 2010-09-29 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US8349120B2 (en) * 2006-03-07 2013-01-08 Ora Health Corporation Multi-layer patch made on a sheet and enclosed in a blister
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US20070248655A1 (en) * 2006-04-21 2007-10-25 Haley Jeffrey T Lenticular shaped protective mouth sore discs
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
US20080160065A1 (en) * 2006-07-12 2008-07-03 Janet Anne Halliday Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
EP3620153A1 (en) 2007-07-06 2020-03-11 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
US20120027855A1 (en) 2007-07-06 2012-02-02 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
WO2009008006A2 (en) * 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions for gastrointestinal drug delivery
EP2163240A1 (en) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova A method for the production of bioadhesive compact matrices
US8652455B2 (en) 2010-12-20 2014-02-18 E I Du Pont De Nemours And Company Targeted perhydrolases
AU2014224238B2 (en) * 2013-03-06 2016-07-14 Novartis Ag Formulations of organic compounds
CN105193768A (zh) * 2015-08-27 2015-12-30 武汉武药科技有限公司 一种曲安奈德口腔粘贴片及其制备工艺
ES2957388T3 (es) * 2016-07-15 2024-01-18 H2 Water Tech Ltd Composición para producir agua rica en hidrógeno

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554764A (en) * 1967-12-21 1971-01-12 Gen Foods Corp Freeze-thaw resistant flour and starch thickener blend
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
EP0451433B1 (en) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Composition of a bioadhesive sustained delivery carrier for drug administration
US5330761A (en) * 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5370878A (en) 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5656283A (en) 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product

Also Published As

Publication number Publication date
EA199800350A1 (ru) 1998-10-29
HK1015680A1 (en) 1999-10-22
DK0869772T3 (da) 2002-01-21
ATE206304T1 (de) 2001-10-15
TR199800894T2 (xx) 1998-08-21
DE69615704D1 (de) 2001-11-08
IL123636A0 (en) 1998-10-30
JP4317264B2 (ja) 2009-08-19
AU713849B2 (en) 1999-12-09
HU228350B1 (hu) 2013-03-28
HUP9802913A2 (hu) 1999-06-28
PT869772E (pt) 2002-03-28
CY2269B1 (en) 2003-07-04
IL123636A (en) 2001-04-30
KR100459029B1 (ko) 2006-03-27
PL326196A1 (en) 1998-08-31
CA2232152C (en) 2007-02-06
NO981027D0 (no) 1998-03-09
JP2000502691A (ja) 2000-03-07
SI0869772T1 (en) 2002-04-30
BR9612291A (pt) 1999-07-13
WO1997024109A1 (en) 1997-07-10
ES2164940T3 (es) 2002-03-01
CN1146401C (zh) 2004-04-21
PL186278B1 (pl) 2003-12-31
SK283370B6 (sk) 2003-06-03
NZ325844A (en) 1999-06-29
HUP9802913A3 (en) 2000-06-28
AU1308597A (en) 1997-07-28
SK88798A3 (en) 1998-11-04
NO981027L (no) 1998-06-15
CN1200667A (zh) 1998-12-02
EP0869772B1 (en) 2001-10-04
US6303147B1 (en) 2001-10-16
CZ298690B6 (cs) 2007-12-27
CZ199298A3 (cs) 1998-09-16
NO320015B1 (no) 2005-10-10
EA000818B1 (ru) 2000-04-24
CA2232152A1 (en) 1997-07-10
EP0869772A1 (en) 1998-10-14
DE69615704T2 (de) 2002-07-11
KR19990067112A (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
ZA9610886B (en) Bioadhesives solid dosage form.
BG105857A (en) Pregelatinized starch in a controlled release formulation
BG66114B1 (bg) Многофазов състав на дросперидон като контрацептив
CA2159580A1 (en) Pharmaceutical Compositions Containing Polyvinylpyrrolidone and a Tri-Ester and Process of Manufacture Thereof
CA2214026A1 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
UA41346C2 (ru) Фармацевтическая композиция, содержащая флуоксетин или его соль, таблетка на ее основе, способ производства диспергируемых таблеток
UA41887C2 (ru) Фармацевтическая композиция, высвобождаемая путем эрозии
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
CA2330480A1 (en) Controlled release formulation of divalproex sodium
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
NZ511900A (en) Sustained release matrix systems for highly soluble drugs
NZ510563A (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
MY121105A (en) Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.